Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion type Assertion NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_head.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion description "[The DNA content of bone marrow cells in patients with acute leukemia preceded by a myelodysplastic stage (MDS-AML) was compared to that in patients with de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_provenance.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion evidence source_evidence_literature NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_provenance.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion SIO_000772 8438903 NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_provenance.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion wasDerivedFrom befree-2016 NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_provenance.
- NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_assertion wasGeneratedBy ECO_0000203 NP1341921.RAUX-nfI2_flPKjoz0-54oup0EZFmGX48ozmv5trd1x_Y130_provenance.